Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Metabolic Benefits In addition to weight loss, semaglutide has demonstrated metabolic benefits that make it appealing for individuals with obesity-related health conditions
Most nasal spray protocols settle on 500mcg administered 2-3 times daily, totaling 1000-1500mcg per day
What It Targets Our AOD-9604 peptides are designed to target: Stubborn body fat and slow fat loss in clients already working on nutrition, steps, and strength training. Mild to moderate central adiposity where clients want incremental support rather than a primary weight-loss medication. Clients who cannot or do not wish to use GLP1s but still want to explore peptide-based metabolic support under a transparent riskbenefit discussion. Aesthetic-focused body recomposition journeys where even small improvements in fatmuscle balance can enhance contouring results
Quick Onset : Administered via an injectable, PT-141 typically takes effect within 3060 minutes
Behavioral and Neurotransmitter Modulation: BPC-157 modulates serotonergic and dopaminergic systems, reducing behavioral disturbances in models of schizophrenia, catalepsy, and amphetamine-induced stereotypy
Exclusions apply
